State Of Wyoming Organogenesis Holdings Inc. Transaction History

State Of Wyoming

$676 Million
Q3 2024

A detailed history of State Of Wyoming transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, State Of Wyoming holds 54,104 shares of ORGO stock, worth $192,069. This represents 0.02% of its overall portfolio holdings.

Number of Shares

54,104

Previous 95,007 43.05%

Holding current value

$192,069

Previous $266,000 42.11%

% of portfolio

0.02%

Previous 0.04%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.42 - $3.24 $98,985 - $132,525	-40,903 Reduced 43.05%	54,104 $154,000
Q2 2024 Aug 14, 2024	BUY	$2.28 - $3.03 $14,368 - $19,095	6,302 Added 7.1%	95,007 $266,000
Q1 2024 May 13, 2024	BUY	$2.61 - $4.49 $74,632 - $128,391	28,595 Added 47.57%	88,705 $251,000
Q4 2023 Feb 14, 2024	SELL	$1.97 - $4.21 $50,841 - $108,651	-25,808 Reduced 30.04%	60,110 $245,000
Q3 2023 Nov 14, 2023	BUY	$2.34 - $4.43 $40,463 - $76,603	17,292 Added 25.2%	85,918 $273,000
Q2 2023 Aug 14, 2023	SELL	$1.9 - $4.3 $2,052 - $4,644	-1,080 Reduced 1.55%	68,626 $227,000
Q1 2023 May 12, 2023	BUY	$1.89 - $2.93 $25,539 - $39,593	13,513 Added 24.05%	69,706 $148,000
Q4 2022 Feb 14, 2023	BUY	$2.48 - $3.43 $59,358 - $82,097	23,935 Added 74.2%	56,193 $151,000
Q3 2022 Nov 14, 2022	BUY	$3.14 - $6.43 $67,365 - $137,949	21,454 Added 198.57%	32,258 $105,000
Q2 2022 Aug 15, 2022	BUY	$4.74 - $8.15 $22,818 - $39,234	4,814 Added 80.37%	10,804 $53,000
Q1 2022 May 13, 2022	BUY	$6.47 - $9.57 $11,037 - $16,326	1,706 Added 39.82%	5,990 $46,000
Q4 2021 Feb 11, 2022	BUY	$9.02 - $13.5 $38,641 - $57,834	4,284 New	4,284 $40,000

Others Institutions Holding ORGO

# of Institutions

117

Shares Held

63.2M

Call Options Held

25K

Put Options Held

23.2K

View Full List

About Organogenesis Holdings Inc.

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $465M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

More about ORGO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.

Account